top of page

Pro Pharmaceuticals Group to Attend Expopharm Munich 2026

  • 1 day ago
  • 2 min read

Pro Pharmaceuticals Group will attend Expopharm 2026 in Munich from 15–17 September, joining pharmacy, pharmaceutical and healthcare stakeholders from across Europe and international markets.


Expopharm is one of Europe’s leading pharmacy-sector events, bringing together more than 500 exhibitors and brands and over 25,000 trade visitors for three days of industry discussion, innovation and business development.


For ProPG, the event provides an important opportunity to strengthen international sourcing relationships and meet partners involved in pharmaceutical import, export, wholesale and medicine access.


Strengthening International Medicine Supply


Australian medicine shortages and special-access requirements increasingly depend on strong international pharmaceutical networks.


ProPG works with licensed suppliers and pharmaceutical partners across multiple markets to identify reliable supply options when medicines are unavailable through routine Australian channels.


At Expopharm, our focus will include discussions around:


  • medicine shortages and difficult-to-source pharmaceuticals

  • international sourcing and wholesale partnerships

  • TGA Section 19A and Special Access Scheme supply

  • hospital medicine access

  • European pharmaceutical sourcing

  • cold-chain and GDP-aligned logistics

  • opportunities to strengthen supply routes between Europe and Australia


Expopharm’s International Meeting Point is particularly relevant to this work, bringing together participants involved in international pharmaceutical trade, including importers, exporters, pharmacists and institutional buyers.


Building Stronger European Supply Relationships

Reliable access to medicines is increasingly dependent on diversified supply networks and trusted relationships across markets.


ProPG continues to strengthen its European pharmaceutical infrastructure and sourcing capabilities, supporting Australian hospitals and pharmaceutical partners where local supply cannot meet clinical demand.


Our attendance at Expopharm Munich forms part of that long-term strategy: building relationships before shortages occur, understanding emerging supply conditions and creating additional pathways for critical medicine access.


Meet ProPG at Expopharm 2026


If you are attending Expopharm and would like to discuss pharmaceutical sourcing, medicine shortages, Australian market access or international supply opportunities, we would be pleased to meet in Munich.


Expopharm 2026

15–17 September 2026

Messe München, Germany


To arrange a meeting with Pro Pharmaceuticals Group, contact info@propg.com.au.


Expo Pharm Pro Pharm
Expopharm Pro Pharm Sept 15th to 17th 2026

Recent Posts
Archive
Search By Tags
Follow Us
  • Twitter Social Icon
  • Google+ Basic Square

Legal & Trademark Notice
© 2026 Pro Pharmaceuticals Group Pty Ltd. All rights reserved.
Pro PG, CheckMed, and their respective logos are registered trademarks owned worldwide by Pro Pharmaceuticals Group Pty Ltd.
Pro Pharmaceuticals Group operates globally through associated entities, including CTS Pharmaceuticals Pty Ltd (Australia), Jemstar Sp. z o.o. (Poland), and Pro Pharmaceuticals Group NZ Ltd (New Zealand).

International Tax Registrations:
ABN 20 605 457 430 (Australia) | VAT DE401757398 (EU VAT ID) | Steuernummer 15/460/00493 (Germany) | VAT PL5263362401 (Poland) | VAT NL825524295B01 (Netherlands).

bottom of page